{"entity":{"type":"insider","cik":"0001575843","url":"/insider/0001575843","json_url":"/insider/0001575843.json","name":"Nashat Amir","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":150,"n_filings":34,"first":"2013-05-14","last":"2025-09-11","span_basis":"filed_date"},"name_variants":[{"name":"Nashat Amir","source":"filing","n_filings":34,"first_seen":"2013-05-14","last_seen":"2025-09-11"}],"transactions":[{"id":5024993,"accession":"0001193125-25-201380","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-201380","line_url":"/filing/0001193125-25-201380","is_derivative":false,"issuer_cik":"0001575843","issuer_name":"Camp4 Therapeutics Corp","issuer_ticker":"CAMP","issuer_name_source":null,"issuer_url":"/issuer/0001575843","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1307189.0,"shares_display":"1,307,189","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":1999999.17,"total_display":"1,999,999.17","total_whole":"1,999,999","shares_owned_after":2825500.0,"shares_owned_after_display":"2,825,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-11","filed_date":"2025-09-11","scope":"insider","n_lines":2},{"id":2086270,"accession":"0001104659-24-108703","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-24-108703","line_url":"/filing/0001104659-24-108703#line-5","is_derivative":false,"issuer_cik":"0001575843","issuer_name":"Camp4 Therapeutics Corp","issuer_ticker":"CAMP","issuer_name_source":null,"issuer_url":"/issuer/0001575843","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":909090.0,"shares_display":"909,090","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":909090.0,"shares_owned_after_display":"909,090","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-15","scope":"insider"},{"id":6117613,"accession":"0000899243-22-023965","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-023965","line_url":"/filing/0000899243-22-023965","is_derivative":false,"issuer_cik":"0001575843","issuer_name":"Scholar Rock Holding Corp","issuer_ticker":"SRRK","issuer_name_source":null,"issuer_url":"/issuer/0001575843","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1197992.0,"shares_display":"1,197,992","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":5870160.8,"total_display":"5,870,160.80","total_whole":"5,870,161","shares_owned_after":3540530.0,"shares_owned_after_display":"3,540,530","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-06-22","filed_date":"2022-06-24","scope":"insider","n_lines":2},{"id":5363809,"accession":"0000899243-21-020599","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-020599","line_url":"/filing/0000899243-21-020599","is_derivative":false,"issuer_cik":"0001575843","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001575843","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":232295.0,"shares_display":"232,295","price_per_share":45.5,"price_display":"45.50","price_state":"stated","total_value":10569422.5,"total_display":"10,569,422.50","total_whole":"10,569,423","shares_owned_after":1953960.0,"shares_owned_after_display":"1,953,960","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-21","filed_date":"2021-05-25","scope":"insider","n_lines":2},{"id":2048769,"accession":"0001209191-20-051504","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-051504","line_url":"/filing/0001209191-20-051504","is_derivative":false,"issuer_cik":"0001575843","issuer_name":"Metacrine, Inc.","issuer_ticker":"MTCR","issuer_name_source":null,"issuer_url":"/issuer/0001575843","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":230000.0,"shares_display":"230,000","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":2990000.0,"total_display":"2,990,000.00","total_whole":"2,990,000","shares_owned_after":214962.0,"shares_owned_after_display":"214,962","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-18","filed_date":"2020-09-22","scope":"insider","n_lines":2},{"id":7909524,"accession":"0000899243-19-020915","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-19-020915","line_url":"/filing/0000899243-19-020915","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30866.0,"shares_display":"30,866","price_per_share":22.529400968703428,"price_display":"22.53","price_state":"stated","total_value":695392.4903,"total_display":"695,392.49","total_whole":"695,392","shares_owned_after":1099772.0,"shares_owned_after_display":"1,099,772","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-01","filed_date":"2019-08-02","scope":"insider","n_lines":4},{"id":7909510,"accession":"0000899243-19-020915","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-020915","line_url":"/filing/0000899243-19-020915","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31139.0,"shares_display":"31,139","price_per_share":22.533601072609912,"price_display":"22.53","price_state":"stated","total_value":701673.8038,"total_display":"701,673.80","total_whole":"701,674","shares_owned_after":1129554.0,"shares_owned_after_display":"1,129,554","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-31","filed_date":"2019-08-02","scope":"insider","n_lines":4},{"id":8608739,"accession":"0000899243-19-020605","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-19-020605","line_url":"/filing/0000899243-19-020605","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90175.0,"shares_display":"90,175","price_per_share":22.5069,"price_display":"22.51","price_state":"stated","total_value":2029559.7075,"total_display":"2,029,559.71","total_whole":"2,029,560","shares_owned_after":1159599.0,"shares_owned_after_display":"1,159,599","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-30","filed_date":"2019-07-30","scope":"insider","n_lines":4},{"id":8608728,"accession":"0000899243-19-020605","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-19-020605","line_url":"/filing/0000899243-19-020605","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":329.0,"shares_display":"329","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":7402.5,"total_display":"7,402.50","total_whole":"7,403","shares_owned_after":1246609.0,"shares_owned_after_display":"1,246,609","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-29","filed_date":"2019-07-30","scope":"insider","n_lines":4},{"id":8608715,"accession":"0000899243-19-020605","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-020605","line_url":"/filing/0000899243-19-020605","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27829.0,"shares_display":"27,829","price_per_share":22.50000097021093,"price_display":"22.50","price_state":"stated","total_value":626152.527,"total_display":"626,152.53","total_whole":"626,153","shares_owned_after":1246926.0,"shares_owned_after_display":"1,246,926","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-26","filed_date":"2019-07-30","scope":"insider","n_lines":4},{"id":8376446,"accession":"0000899243-19-020426","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-19-020426","line_url":"/filing/0000899243-19-020426","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19866.0,"shares_display":"19,866","price_per_share":22.505700664451826,"price_display":"22.51","price_state":"stated","total_value":447098.2494,"total_display":"447,098.25","total_whole":"447,098","shares_owned_after":1273778.0,"shares_owned_after_display":"1,273,778","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-24","filed_date":"2019-07-25","scope":"insider","n_lines":4},{"id":8376430,"accession":"0000899243-19-020426","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-020426","line_url":"/filing/0000899243-19-020426","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62033.0,"shares_display":"62,033","price_per_share":22.50500066255058,"price_display":"22.51","price_state":"stated","total_value":1396052.7061,"total_display":"1,396,052.71","total_whole":"1,396,053","shares_owned_after":1292946.0,"shares_owned_after_display":"1,292,946","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-23","filed_date":"2019-07-25","scope":"insider","n_lines":4},{"id":7808167,"accession":"0000899243-19-020033","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-19-020033","line_url":"/filing/0000899243-19-020033","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48704.0,"shares_display":"48,704","price_per_share":22.5241996940703,"price_display":"22.52","price_state":"stated","total_value":1097018.6219,"total_display":"1,097,018.62","total_whole":"1,097,019","shares_owned_after":1352800.0,"shares_owned_after_display":"1,352,800","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-22","filed_date":"2019-07-22","scope":"insider","n_lines":4},{"id":7808155,"accession":"0000899243-19-020033","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-19-020033","line_url":"/filing/0000899243-19-020033","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1053.0,"shares_display":"1,053","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":23692.5,"total_display":"23,692.50","total_whole":"23,693","shares_owned_after":1399792.0,"shares_owned_after_display":"1,399,792","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-19","filed_date":"2019-07-22","scope":"insider","n_lines":4},{"id":7808146,"accession":"0000899243-19-020033","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-020033","line_url":"/filing/0000899243-19-020033","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21409.0,"shares_display":"21,409","price_per_share":22.504299089168107,"price_display":"22.50","price_state":"stated","total_value":481794.5392,"total_display":"481,794.54","total_whole":"481,795","shares_owned_after":1400808.0,"shares_owned_after_display":"1,400,808","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-18","filed_date":"2019-07-22","scope":"insider","n_lines":4},{"id":8622516,"accession":"0001179110-19-008259","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001179110-19-008259","line_url":"/filing/0001179110-19-008259#line-8","is_derivative":false,"issuer_cik":"0001575843","issuer_name":"Morphic Holding, Inc.","issuer_ticker":"MORF","issuer_name_source":null,"issuer_url":"/issuer/0001575843","owner_cik":"0001575843","owner_name":"Nashat Amir","owner_display_name":"Nashat Amir","owner_url":"/insider/0001575843","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":116827.0,"shares_display":"116,827","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1752405.0,"total_display":"1,752,405.00","total_whole":"1,752,405","shares_owned_after":2171067.0,"shares_owned_after_display":"2,171,067","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-07-01","filed_date":"2019-07-01","scope":"insider"}],"collapsed":true,"next_cursor":"2019-07-01|8622516","ledger_fault":false,"count":{"value":150,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":26,"open_market":true},{"code":"S","label":"Open-market sale","n":124,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":150},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001736730","name":"Camp4 Therapeutics Corp","url":"/issuer/0001736730","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2024-10-15","last_seen":"2025-09-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001727196","name":"Scholar Rock Holding Corp","url":"/issuer/0001727196","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2018-05-31","last_seen":"2022-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001679363","name":"Morphic Holding, Inc.","url":"/issuer/0001679363","role":"Director","n_filings":2,"first_seen":"2019-07-01","last_seen":"2021-05-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001634379","name":"Metacrine, Inc.","url":"/issuer/0001634379","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2020-09-22","last_seen":"2020-09-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001434316","name":"FATE THERAPEUTICS INC","url":"/issuer/0001434316","role":"Director, Ten percent owner","n_filings":15,"first_seen":"2013-10-07","last_seen":"2019-08-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001453687","name":"SELECTA BIOSCIENCES INC","url":"/issuer/0001453687","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2016-06-29","last_seen":"2019-01-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001556263","name":"Syros Pharmaceuticals, Inc.","url":"/issuer/0001556263","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2016-07-07","last_seen":"2016-07-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001463729","name":"Receptos, Inc.","url":"/issuer/0001463729","role":"Director","n_filings":6,"first_seen":"2013-05-14","last_seen":"2013-12-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001575843","retrieved_at":"2026-08-26T16:54:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}